Hereditary predisposition to breast cancer

Current Opinion in Genetics and Development

Volumn 6, Issue 1, 1996, Pages 93-97

  Stratton, Michael R ^a   Wooster, Richard ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC FINGER PROTEIN;

BREAST CANCER; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 13Q; CHROMOSOME 17Q; FEMALE; FOUNDER EFFECT; GENE LOCATION; GENE MUTATION; GENE STRUCTURE; GERM LINE; HUMAN; MALE; MALE BREAST; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; SOMATIC MUTATION;

EID: 0030026142     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(96)90017-9     Document Type: Article

References (33)

1. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA Huey B, King MC: Linkage of early-onset familial breast cancer to Chromosoms 17q21. Science 1990, 250:1684-1689.
2. Easton DP, Bishop DT, Ford D, Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993, 52:678-701.
3. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994, 343:692-695.
4. Miki Y, Swensen J, Shattuck Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
5. The isolation of BRCA1.
6. Marquis ST, Rajan JV, Wynshaw-Boris A, Xui J, Yin G-Y, Abel K, Weber BL, Chodosh LA: The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nature Genet 1995, 11:17-26.
7. A detailed study of BRCA1 expression patterns in mice.
8. Brown MA, Nicolai H, Xu CF, Griffiths BL, Jones KA, Solomon E, Hosking L, Trowsdale J, Black DM, McFarlane R: Regulation of BRCA1 [letter]. Nature 1994, 372:733.
9. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M et al.: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995, 273:535-541.
10. Struewing JP, Brody LC, Erdos MR, Kase RG, Giambarresi TR, Smith SA, Collins FS, Tucker MA: Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995, 57:1-7.
11. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC: Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet 1994, 8:399-404.
12. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc JF, Belanger C, Dion F et al.: Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet 1994, 8:392-398.
13. Boyd M, Harris F, McFarlane R, Davidson HR, Black DM: A human BRCA1 gene knockout [letter]. Nature 1995, 375:541-542. A BRCA1 homozygote.
14. Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, Narod S: BRCA1 mutations in Ashkenazi Jewish women [letter]. Am J Hum Genet 1995, 57:189.
15. Neuhausen SL, Marshall CJ: Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res 1994, 54:6069-6072.
16. Kelsell DP, Black DM, Bishop DT, Spurr NK: Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum Mol Genet 1993, 2:1823-1828.
17. Smith SA, Easton DF, Evans DG, Ponder BA: Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet 1992, 2:128-131.
18. Cornelis RS, Neuhausen SL, Johansson O, Arason A, Kelsell D, Ponder BAJ, Tonin P et al.: High allele loss rates at 17q12-21 in breast and ovarian tumors from BRCA1-linked families. Genes Chromosomes Cancer 1995, 13:203-210.
19. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y et al.: BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994, 266:120-122.
20. Reports the original observation that somatic BRCA1 mutations are uncommon in sporadic cancers.
21. Takahashi H, Behbakht K, McGovern PE, Chiu HC, Couch FJ, Weber BL, Friedman LS, King MC, Furusato M, LiVolsi VA: Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 1995, 55:2998-3002.
22. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS: Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet 1995, 9:439-443.
23. Hosking L, Trowsdale J, Nicolai H, Solomon E, Foulkes W, Stamp G, Signer E, Jeffreys A: A somatic BRCA1 mutation in an ovarian tumour [letter]. Nature Genet 1995, 9:343-344.
24. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet 1995, 9:444-450.
25. Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman US, King MC, Egilsson V, Devilee P, McManus R et al.: Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nature Genet 1994, 7:103-107.
26. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D et al.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994, 265:2088-2090.
27. The localization of BRCA2.
28. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani SR, Ormiston W, Daly PA, Ford D, Easton DF et al.: Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogens 1995, 10:1673-1675.
29. Schutte M, Da Costa LT, Hahn SA, Moskaluk C, Hoque AT, Rozenblum E, Weinstein CL, Bittner M, Meltzer PS, Trent JM: Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA 1995, 92:5950-5954.
30. Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BA, Weber BL, Garber JE, Birch JM et al.: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet 1995, 56:254-264.
31. Kerangueven F, Essioux L, Dib A, Noguchi T, Allione F, Geneix J, Longy M, Lidereau R, Eisinger F, Pebusque MJ et al.: Loss of heterozygosity and linkage analysis in breast carcinoma: Indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 1995, 10:1023-1026.
32. Starink TM, Van der Veen JP, Arwert F, De Waal LP, De Lange GG, Gille JJ, Eriksson AW: The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986, 29:222-233,.
33. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995, 268:1749-1753.